Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,502 | -4,365 | -16,168 | -12,611 | -9,062 |
| Depreciation Amortization | 168 | 99 | 507 | 405 | 324 |
| Other Working Capital | -1,664 | -1,635 | -5,349 | -5,590 | -4,182 |
| Other Operating Activity | 793 | 415 | 1,024 | 852 | 736 |
| Operating Cash Flow | $-10,205 | $-5,486 | $-19,986 | $-16,944 | $-12,184 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,752 | 8,741 | -7,123 | -6,057 | -1,839 |
| PPE Investments | N/A | N/A | -134 | -134 | -11 |
| Net Acquisitions | N/A | N/A | 2,550 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 2,550 | 2,500 |
| Investing Cash Flow | $10,752 | $8,741 | $-4,707 | $-3,641 | $650 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,038 | 1,000 | 1,386 | 1,353 | 630 |
| Other Financing Activity | -130 | -130 | -562 | -562 | -539 |
| Financing Cash Flow | $908 | $870 | $824 | $791 | $91 |
| Beginning Cash Position | 10,299 | 10,299 | 34,168 | 34,168 | 34,168 |
| End Cash Position | 11,754 | 14,424 | 10,299 | 14,374 | 22,725 |
| Net Cash Flow | $1,455 | $4,125 | $-23,869 | $-19,794 | $-11,443 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,205 | -5,486 | -19,986 | -16,944 | -12,184 |
| Capital Expenditure | N/A | 0 | -134 | -134 | -11 |
| Free Cash Flow | -10,205 | -5,486 | -20,120 | -17,078 | -12,195 |